M. Hofman

1.1k total citations · 1 hit paper
11 papers, 804 citations indexed

About

M. Hofman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, M. Hofman has authored 11 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in M. Hofman's work include Cancer Treatment and Pharmacology (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Prostate Cancer Treatment and Research (3 papers). M. Hofman is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Prostate Cancer Treatment and Research (3 papers). M. Hofman collaborates with scholars based in United States. M. Hofman's co-authors include Gary R. Morrow, Julie L. Ryan, Colmar Figueroa-Moseley, Pascal Jean‐Pierre, Jane T. Hickok, Karen M. Mustian, Joseph A. Roscoe, Tom R. Fitch, James L. Wade and Dennis F. Moore and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Oncologist.

In The Last Decade

M. Hofman

10 papers receiving 767 citations

Hit Papers

Cancer-Related Fatigue: The Scale of the Problem 2007 2026 2013 2019 2007 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Hofman United States 4 575 312 263 106 83 11 804
C. Verhagen Netherlands 12 416 0.7× 237 0.8× 208 0.8× 189 1.8× 131 1.6× 25 875
D. Storey United Kingdom 12 541 0.9× 201 0.6× 171 0.7× 80 0.8× 84 1.0× 22 858
Mauro Guglielmo Italy 9 323 0.6× 154 0.5× 156 0.6× 49 0.5× 71 0.9× 13 580
Sarah Dauchy France 15 451 0.8× 165 0.5× 206 0.8× 91 0.9× 37 0.4× 71 912
Pleun J. de Raaf Netherlands 8 362 0.6× 190 0.6× 130 0.5× 62 0.6× 38 0.5× 10 575
John Saxton United Kingdom 14 852 1.5× 345 1.1× 271 1.0× 57 0.5× 298 3.6× 18 1.1k
Ichiro Mikami Japan 10 575 1.0× 287 0.9× 201 0.8× 92 0.9× 58 0.7× 12 846
Frances Cartwright United States 15 370 0.6× 180 0.6× 211 0.8× 33 0.3× 45 0.5× 35 659
Arash Asher United States 17 308 0.5× 142 0.5× 281 1.1× 106 1.0× 50 0.6× 50 791
Leslee Thompson Canada 6 449 0.8× 268 0.9× 147 0.6× 159 1.5× 32 0.4× 14 615

Countries citing papers authored by M. Hofman

Since Specialization
Citations

This map shows the geographic impact of M. Hofman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Hofman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Hofman more than expected).

Fields of papers citing papers by M. Hofman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Hofman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Hofman. The network helps show where M. Hofman may publish in the future.

Co-authorship network of co-authors of M. Hofman

This figure shows the co-authorship network connecting the top 25 collaborators of M. Hofman. A scholar is included among the top collaborators of M. Hofman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Hofman. M. Hofman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Perera, María, Nathan Papa, Mary Flynn Roberts, et al.. (2019). Clinical utility of PSMA PET in biochemically recurrent prostate cancer: A systematic review and meta-analysis. European Urology Supplements. 18(11). e3497–e3497. 1 indexed citations
2.
Perera, María, Daniel Christidis, David Wetherell, et al.. (2016). Effect of PSA on diagnostic yield of 68Ga-PSMA PET in advanced prostate cancer: A systematic review and meta-analysis. European Urology Supplements. 15(12). e1540–e1540. 2 indexed citations
3.
Perera, María, Nathan Papa, Daniel Christidis, et al.. (2016). Sensitivity, specificity of 68Ga-PSMA PET in advanced prostate cancer: A systematic review and meta-analysis. European Urology Supplements. 15(12). e1539–e1539. 2 indexed citations
4.
Kirshner, Jeffrey J., Jane T. Hickok, & M. Hofman. (2007). Pegfilgrastim-induced bone pain: incidence, risk factors, and management in a community practice. Community Oncology. 4(7). 455–458. 21 indexed citations
5.
Hofman, M., Julie L. Ryan, Colmar Figueroa-Moseley, Pascal Jean‐Pierre, & Gary R. Morrow. (2007). Cancer-Related Fatigue: The Scale of the Problem. The Oncologist. 12(S1). 4–10. 665 indexed citations breakdown →
6.
Hofman, M., Gary R. Morrow, Pascal Jean‐Pierre, et al.. (2006). Chemotherapy-naïve cancer patients’ expectations of developing treatment-related side effects: A URCC CCOP study of 670 patients from community practices. Journal of Clinical Oncology. 24(18_suppl). 8509–8509.
7.
Hofman, M., et al.. (2005). Cancer treatment side effects in breast cancer patients receiving radiation therapy. Journal of Clinical Oncology. 23(16_suppl). 705–705. 4 indexed citations
8.
Hofman, M., Gary R. Morrow, Joseph A. Roscoe, et al.. (2004). Cancer patients' expectations of experiencing treatment‐related side effects. Cancer. 101(4). 851–857. 106 indexed citations
9.
Morrow, Gary R., Karen M. Mustian, M. Hofman, et al.. (2004). Are cancer patients utilizing complementary therapies? A URCC CCOP study. Journal of Clinical Oncology. 22(14_suppl). 8157–8157. 1 indexed citations
10.
Mustian, Karen M., M. Hofman, Peter Bushunow, et al.. (2004). Are cancer patients utilizing complementary therapies? A URCC CCOP study. Journal of Clinical Oncology. 22(14_suppl). 8157–8157. 1 indexed citations
11.
Hofman, M., Joseph A. Roscoe, Jane T. Hickok, et al.. (2004). Impact of information sources on expectation of cancer treatment side effects: A URCC CCOP study. Journal of Clinical Oncology. 22(14_suppl). 8094–8094. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026